26 results
·
38ms
·
Sources: EU EUDAMED, US FDA
MAGNATHERM 2000
FDA 510(k)
FDA Class 2
·Physical Medicine
N.A.
FDA UDI
Forestadent Bernhard Förster GmbH·EFOR27715401·DuoForce wires mand. .016"x.016"
SBI TITANIUM THREADED PIN
FDA 510(k)
FDA Class 2
·Orthopedic
Refobacin Bone Cement R
FDA 510(k)
FDA Class 2
·Orthopedic
REFOBACIN BONE CEMENT R 1X40-3
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·March 30, 2026
REFOBACIN BONE CEMENT R 1X40-3
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·February 24, 2026
OPTIPAC 80 REFOB PLUS BONE CMT-3
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·March 17, 2026
EASYTRAK 2
FDA Adverse Event
Injury
·CPI - DEL CARIBE·Product code NIK·April 24, 2014
SYNCHROMED II
FDA Adverse Event
Injury
·MDT PUERTO RICO OPERATIONS CO·Product code LKK·October 4, 2012
VITALITY
FDA Adverse Event
Injury
·GUIDANT CRM CLONMEL IRELAND·Product code LWS·July 27, 2010
REFOBACIN BONE CEMENT R 2X40G
FDA Adverse Event
Injury
·BIOMET UK LTD.·Product code MBB·March 12, 2026
REFOBACIN BONE CEMENT R 2X20-3
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·February 11, 2026
REFOBACIN BONE CEMENT R 2X40G
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·February 20, 2026
OPTIPAC 80 REFOB BONE CMT R-3
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code LOD·November 14, 2025
REFOBACIN BONE CEMENT R 1X40-3
FDA Adverse Event
Death
·BIOMET FRANCE S.A.R.L.·Product code MBB·December 15, 2025
REFOBACIN BONE CEMENT R 1X40-3
FDA Adverse Event
Malfunction
·BIOMET FRANCE S.A.R.L.·Product code MBB·December 30, 2024
REFOBACIN BONE CMNT R 1X40 JP
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·May 7, 2025
OPTIPAC 40 REFOB BONE CMT R-3
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·February 5, 2026
OPTIPAC 60 REFOB BONE CMT R-3
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·February 5, 2026
OPTIPAC 60 REFOB BONE CMT R-3
FDA Adverse Event
Injury
·BIOMET FRANCE S.A.R.L.·Product code MBB·January 30, 2026